For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
search
Documents
Pharmaceutical Tablet and Capsule Excipients by Gel Permeation Chromatography (GPC) (TN-1155)
Using Gel Permeation Chromatography (GPC), polymers are separated and characterized based ont heir size in solution which is directly related to their molevular weight and degree of polymerization (Dp).

Pharmaceutical Tablet and Capsule Excipients by Gel Permeation Chromatography (GPC) (TN-1155)

Using Gel Permeation Chromatography (GPC), polymers are separated and characterized based ont heir size in solution which is directly related to their molevular weight and degree of polymerization (Dp).
Document Type:
Technical Notes
Target Industries:
Biopharmaceutical Analysis, Pharmaceutical
Techniques:
HPLC, HPLC-SEC
Brands:
Phenogel
Separation Modes:
Size Exclusion
Phases:
Phenogel 100 Å , Phenogel 500 Å , Phenogel 50 Å , Phenogel Linear(2)
save_alt Download
favorite_border
Phenomenex logo
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US

PRODUCTS AND SERVICES

Products

Techniques

Industries

Quick Order

SUPPORT 

Product/Method Support

Product Troubleshooting

Contact Us

CQA / CofA


OUR COMPANY

About Phenomenex

News

Blog

Danaher Life Sciences


Terms and Conditions Privacy Statement Quality Policy Terms of Use Trademarks CA Supply Chains Act CA Consumer Privacy Act Cookie Policy Impressum © 2023 Phenomenex Inc. All rights reserved.